MWVC
ABBV icon

Morgens Waterfall Vintiadis & Co’s AbbVie ABBV Stock Holding History

Morgens Waterfall Vintiadis & Co’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,120
Closed -$295K – 60
2018
Q3 		$295K Buy
+3,120
New +$296K 0.19% 56
2018
Q2 		– Sell
-13,965
Closed -$1.32M – 55
2018
Q1 		$1.32M Buy
13,965
+8,300
+147% +$912K 1.01% 32
2017
Q4 		$548K Buy
+5,665
New +$534K 0.43% 39

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Morgens Waterfall Vintiadis & Co's ABBV Position: Q4 2018 in Review

Morgens Waterfall Vintiadis & Co sold out of AbbVie (ABBV) in Q4 2018, closing a stake of 3,120 shares — an estimated $295K sold.

Morgens Waterfall Vintiadis & Co first reported a position in ABBV in Q4 2017 and held it in 3 quarters. The position peaked at $1.32M in Q1 2018. 2,063 funds tracked by Wall St. Rank hold ABBV as of Q4 2018.

  • Morgens Waterfall Vintiadis & Co reported no remaining AbbVie position as of Q4 2018 after selling out during the quarter.
  • Morgens Waterfall Vintiadis & Co sold 3,120 AbbVie shares in Q4 2018, an estimated $295K.
  • Morgens Waterfall Vintiadis & Co first reported a position in AbbVie in Q4 2017 and held it in 3 quarters.
  • Morgens Waterfall Vintiadis & Co's AbbVie position peaked at $1.32M in Q1 2018.
  • 2,063 funds tracked by Wall St. Rank held AbbVie as of Q4 2018.

Based on Morgens Waterfall Vintiadis & Co's 13F filing for Q4 2018, filed 14 Feb 2019.